Welcome to the

Pascoal Lab

About the

Lab

Our lab is interested in the quantification of brain pathophysiology in patients with Alzheimer’s disease (AD) and related dementias as well as in the validation of therapies capable of modifying the course of these diseases producing an enduring disease-modifying and clinically relevant effect. This involves the validation of positron emission tomography (PET) and fluid biomarker techniques capable of measuring these brain pathologies and monitoring their progression.

Research in

Focus

Recent

Publications

Nature Communications

Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease

Alzheimer’s & Dementia

Plasma GFAP for populational enrichment of clinical trials in preclinical Alzheimer’s disease

Alzheimer’s & Dementia

Impact of the polygenic risk scores for attention-deficit/hyperactivity disorder in Alzheimer’s disease

JAMA Network

Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease

Nature Aging

APOEε4 potentiates amyloid β effects on longitudinal tau pathology

Alzheimer’s & Dementia

Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals

Show more

Funding

Affiliations

Funding

Affiliations